News
-
-
-
-
REGULATED PRESS RELEASE
imerys-14-05-2024-regulated-information-publication-of-the-report-on-payments-made-to-governments (final)
Imerys publishes report on payments made to governments, available on company website. Leading global supplier of mineral-based solutions promoting responsible development -
-
-
REGULATED PRESS RELEASE
Imerys-press-release-Q1-2024-results-30-April-2024-VENGFinal
Imerys delivers robust first quarter 2024 results with 9% year-on-year increase in adjusted EBITDA, showcasing positive commercial actions and strategic initiatives. Progress in strategic roadmap includes new business area for Energy Transition solutions -
REGULATED PRESS RELEASE
imerys-30-april-2024-information-share-capital-and-voting-rights-as-of-31-march-2024 (2)
Imerys publishes number of outstanding shares and voting rights as of 31 March 2024 in compliance with French regulations. The company is a global leader in mineral-based specialty solutions for various industries -
-
REGULATED PRESS RELEASE
Press Release Imerys - Entry into exlusive negotiations to acquire Chemviron's European diatomite and perlite business
Imerys to acquire Chemviron's European diatomite and perlite business, enhancing product portfolio and market reach. Transaction expected to be completed by year end
![Accesswire](/assets/images/accesswire-inline.png)
-
APWG 2024 Cybercrime Research Conference Extends Submission Deadline to July 7
-
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
-
XS Financial Enters Into Definitive Agreement to Be Taken Private
-
TRU Engages Investor Relations Specialists HE Capital Markets
-
DuJour Media Jason Binn Celebrates Successful 12th Anniversary Cover Party with Star-Studded After-Party and Record Turnout
![EQS Group](/assets/images/eqs-group.png)
-
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
-
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
-
Meyer Burger makes significant progress in relocating its core business to the USA
-
BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
-
CureVac Announces Voting Results of General Meeting
![Les Echos](/assets/images/les-echos.png)
-
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2024
-
2023/2024 Third Quarter Sales
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024. Detailed information per transaction
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024
-
imerys-24-06-2024-information-share-capital-and-voting-rights-as-of-31-may-2024